Company intelligence / Profile preview

ARK Investment Management

St. Petersburg, Florida, United Statesark-invest.com ↗

Ownership: Private
Development stage: Other

Overview

ARK Investment Management ("ARK Invest") is an active investment management firm specializing in thematic investing focused on disruptive innovation. While it does not itself conduct drug development or clinical research, it manages several funds—including the Genomic Revolution ETF—that invest in companies across genomics, biotechnology, and healthcare innovation. The firm’s strategies are designed to provide exposure to sectors such as artificial intelligence, robotics, energy storage, DNA sequencing/genomics technologies, and blockchain.

Industry: Investors

Partnerships

Nikko Asset Management21Shares

Beyond the preview

Go deeper on ARK Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARK Investment Management.

Explore the full profile